SME
Biopharmaceutical, COVID-19, Manufacturing

Perhaps the biggest achievement thus far at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has been disabusing companies that are members of the Manufacturing USA innovation institute that it is smart to be “a fast second” to market.

“Nobody actually believed when we started, except apparently us naively, that...